We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.

Canadian Sec - Delayed Quote CAD

Core One Labs Inc. (COOL.CN)

0.1450

0.0000

(0.00%)

At close: August 1 at 9:30 a.m. EDT

Key Events

Loading Chart for COOL.CN

9/21 12:03 PM

DELL

Previous Close 0.1450
Open 0.0000
Bid 0.0100 x --
Ask 0.2000 x --
Day's Range 0.1450 - 0.1450
52 Week Range 0.0900 - 0.5500
Volume 0
Avg. Volume 0
Market Cap (intraday) 6.829M
Beta (5Y Monthly) 1.31
PE Ratio (TTM) --
EPS (TTM) -0.1100
Earnings Date --
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.

--

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Core One Enters into Loan Agreement with Right Season Investments

Core One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International Market

Core One Labs’ Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer’s and Parkinson’s, Showing Potential to Outperform Current Treatment Methods

Trailing total returns as of 2024-11-01, which may include dividends or other distributions. Benchmark is

S&P/TSX Composite index

.

YTD Return

COOL.CN

50.00%

S&P/TSX Composite index

15.73%

1-Year Return

COOL.CN

48.21%

S&P/TSX Composite index

28.51%

3-Year Return

COOL.CN

90.58%

S&P/TSX Composite index

15.30%

5-Year Return

COOL.CN

97.89%

S&P/TSX Composite index

47.15%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Core One Labs Inc.

0.1450

0.00%

Mkt Cap CAD 6.829M

Industry Biotechnology

HAVN Life Sciences Inc.

0.0300

0.00%

Mkt Cap CAD 442,158

Industry Biotechnology

America Great Health

0.0005

0.00%

Mkt Cap 10.595M

Industry Biotechnology

Aptose Biosciences Inc.

0.5300

+1.92%

Mkt Cap CAD 9.598M

Industry Biotechnology

Chromocell Therapeutics Corporation

0.6420

+3.50%

Mkt Cap 3.702M

Industry Biotechnology

Evaxion Biotech A/S

2.5900

-1.15%

Mkt Cap 14.447M

Industry Biotechnology

Edesa Biotech, Inc.

3.2000

-0.62%

Mkt Cap 10.392M

Industry Biotechnology

Avenue Therapeutics, Inc.

2.2400

-7.44%

Mkt Cap 3.206M

Industry Biotechnology

Enzolytics, Inc.

0.0016

+6.67%

Mkt Cap 5.859M

Industry Biotechnology

Medicenna Therapeutics Corp.

2.5100

+6.36%

Mkt Cap CAD 191.846M

Industry Biotechnology

1.7000

-11.92%

Mkt Cap 1.45M

Industry Biotechnology

Valuation Measures

As of 2024-10-29

Market Cap

6.83M
Enterprise Value

6.92M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

14.41
Price/Book (mrq)

1.21
Enterprise Value/Revenue

10.68
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

--
Return on Equity (ttm)

--
Revenue (ttm)

458.54k
Net Income Avi to Common (ttm)

-15.98M
Diluted EPS (ttm)

-0.1100

Balance Sheet and Cash Flow

Total Cash (mrq)

154.82k
Total Debt/Equity (mrq)

4.43%
Levered Free Cash Flow (ttm)

--